The DOI matches its Crossref record; the references it cites are not checked yet.
The effect of weight loss program on serum anti-Müllerian hormone level in obese and overweight infertile women with polycystic ovary syndrome
Abstract
We evaluated the predictive value of serum anti-Müllerian hormone (AMH) levels for improved menstrual cycles in response to dietary management in women with polycystic ovary syndrome (PCOS). In addition, we assessed the effect of a restricted calorie diet for 12 weeks on serum AMH levels. This intervention study was carried out at Rohan Institute, Tehran, Iran from 2013 to 2015. A total of 105 overweight and obese women with PCOS and reproductive impairment participated in a 12-week weight loss program (WLP). The serum AMH levels, weight, and menstrual cyclicity were assessed at baseline and post-intervention for all of the participants. A total of 90 patients completed the 12-week WLP. Of the 90 patients, 65 (72.2%) responded to the intervention with improvements in menstrual cyclicity. There were no significant differences in terms of age, baseline AMH levels, and other hormone profiles between responders and nonresponders. Responders had a significantly lower baseline body mass index (BMI) and waist circumference compared with nonresponders. These factors were the clinical predictors for a menstrual response after the intervention. The AMH levels did not significantly change after 12-week WLP despite the overall reduced weight; however, women who responded with improved reproductive function had a greater reduction in AMH levels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
With a 1000 kcal/day deficit intervention, researchers found significant decreases in weight, waist circumference, and fasting insulin.
“With a 1000 kcal/day deficit intervention, researchers found significant decreases in weight, WC, and fasting insulin [70].”
From Moving beyond Weight: A Narrative Review of the Dietary and Lifestyle Management for Reducing Cardiometabolic Risk in Polycystic Ovary Syndrome (PCOS) (2023) · cites this paper as [70]
Citations
The citation lists haven’t been fetched yet
References 15 · Cited by 12
Research works printed but not linked: 15
- 10.2217/whe-2016-0005 · DOI
- 10.1111/j.1365-2265.2006.02587.x · DOI
- 10.1111/j.1471-0528.2006.00990.x · DOI · Paper page
- Moran LJ, 2011, Cochrane Database Syst Rev, CD007506
- Hampl R, 2011, Physiol Res, 60, 217, 10.33549/physiolres.932076 · DOI
- 10.1016/S0015-0282(01)02944-2 · DOI
- 10.1152/ajpendo.90684.2008 · DOI
- 10.1016/j.fertnstert.2011.04.003 · DOI
- Tal R, 2014, Am J Obstet Gynecol, 211, e1
- 10.1016/j.rbmo.2016.01.010 · DOI
- 10.1210/jc.2007-1188 · DOI
- 10.1093/humrep/dep101 · DOI
- 10.3109/09513590.2012.736557 · DOI · Paper page
- 10.1016/j.fertnstert.2013.06.030 · DOI
- 10.1093/humrep/deh098 · DOI · Paper page
Metadata
- Authors
- Moini, A., Arabipoor, A., Hemat, M., Ahmadi, J., Salman-Yazdi, R., & Zolfaghari, Z.
- Affiliations
- Royan Institute (IR)
- Department of Andrology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran
- Corresponding author
- Hemat, Mandana
- Venue
- Gynecological Endocrinology
- Publisher
- Informa UK Limited
- Published
- 2018-12-22
- Volume
- 35
- Issue
- 2
- Pages
- 119-123
- ISSN
- 0951-3590 (ISSN-L)
- 1473-0766
- OpenAlex
- W2905637900
- Cited by
- 12
- References
- 15
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 1 · 2019: 1
- FWCI
- 1.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gynecological Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Royan Institute
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Keywords
- polycystic ovary syndrome, anti-Müllerian hormone, weight loss, obesity, overweight, menstrual cyclicity, dietary management, caloric restriction, body mass index, waist circumference, infertility, predictors of treatment response
- MeSH terms
- Adult, Female, Humans, Infertility, Female, Insulin, Iran, Obesity, Polycystic Ovary Syndrome, Testosterone, Body Mass Index, Multivariate Analysis, Logistic Models, Treatment Outcome, Caloric Restriction, Overweight, Anti-Mullerian Hormone, Waist Circumference, Young Adult, Weight Reduction Programs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
